Lobbyist: Federal Drug Reform Action Unlikely

Lobbyist Greg Means believes federal action into horse racing medication reform is unlikely, which could be a blow to The Jockey Club’s advocacy for reform and a boon to those who support the continued use of furosemide.
Share
Favorite
Close

No account yet? Register

ADVERTISEMENT

Advocates for change in horse racing didn't find much reason for optimism in the National Thoroughbred Racing Association's legislative update held Aug. 7 in Saratoga Springs, New York.

The presentation from lobbyist Greg Means, founder and principal of The Alpine Group in Washington, D.C., reviewed current legislation or proposals that pertain to racing. Included were bills covering the ways gamblers' winnings are reported and taxed, the acceleration of depreciation of Thoroughbreds for tax purposes, which expired at the end of 2013, and medication reform.

Means assessed the viability of federal intervention into the regulation of medication in racing, specifically a bill that would install the United States Anti-Doping Association as the regulator to develop guidelines and rules regarding medication use.

"What I think is going to happen to this bill," he said, "is nothing

Create a free account with TheHorse.com to view this content.

TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.

Start your free account today!

Already have an account?
and continue reading.

Share

Written by:

Related Articles

Stay on top of the most recent Horse Health news with

FREE weekly newsletters from TheHorse.com

Sponsored Content

Weekly Poll

sponsored by:

How much time do you usually spend grooming your horse?
439 votes · 439 answers

Readers’ Most Popular

Sign In

Don’t have an account? Register for a FREE account here.

Need to update your account?

You need to be logged in to fill out this form

Create a free account with TheHorse.com!